Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2017 · 10-Q
Revenue$130.00K$130.00K+11.1% vs Q3 2016 Net Income-$3.00M-$3.00MN/M vs Q3 2016 EPS Diluted-$0.08-$0.08N/M vs Q3 2016 Operating Income-$3,039,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,784,000— Margins · derivedOperating margin-2337.7%−900.1 pt vs Q3 2016
Net margin-2308.5%+472.7 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 9, 2017 · 40 d after period end